Wnt signalling suppresses voltage-dependent Na+ channel expression in postnatal rat cardiomyocytes

Wenbin Liang, Hee Cheol Cho, Eduardo Marbán

Research output: Contribution to journalArticle

Abstract

Key points: Wnt signalling is activated in arrhythmogenic heart diseases, but its role in the regulation of cardiac ion channel expression is unknown. Exposure of neonatal rat ventricular myocytes to Wnt3a, an activator of canonical Wnt signalling, decreases Scn5a mRNA, Nav1.5 protein and Na+ current density. Wnt3a does not affect the inward rectifier K+ current or L-type Ca2+ channels. The Wnt pathway is a negative regulator of cardiac Na+ channel expression and may play a role in altered ion channel expression in heart disease. Wnt signalling plays crucial roles in heart development, but is normally suppressed postnatally. In arrhythmogenic conditions, such as cardiac hypertrophy and heart failure, Wnt signalling is reactivated. To explore the potential role of Wnt signalling in arrhythmogenic electrical remodelling, we examined voltage-dependent ion channels in cardiomyocytes. Treatment of neonatal rat ventricular myocytes with either recombinant Wnt3a protein or CHIR-99021 (CHIR, a glycogen synthase kinase-3β inhibitor) caused a dose-dependent increase in Wnt target gene expression (Axin2 and Lef1), indicating activation of the Wnt/β-catenin pathway. Cardiac Na+ current (INa) density was reduced by Wnt3a (-20 ± 4 vs. control -59 ± 7 pA pF-1, at -30 mV) or CHIR (-22 ± 5 pA pF-1), without changes in steady-state activation, inactivation or repriming kinetics. Wnt3a and CHIR also produced dose-dependent reductions in the mRNA level of Scn5a (the cardiac Na+ channel α subunit gene), as well as a 56% reduction (by Wnt3a) in the Nav1.5 protein level. Consistent with INa reduction, action potentials in Wnt3a-treated neonatal rat ventricular myocytes had a lower upstroke amplitude (91 ± 3 vs. control 137 ± 2 mV) and decreased maximum upstroke velocity (70 ± 10 vs. control 163 ± 15 V s-1). In contrast, inward rectifier K+ current and L-type Ca2+ channels were not affected by Wnt3a treatment. Taken together, our data indicate that the Wnt/β-catenin pathway suppresses INa in postnatal cardiomyocytes and may contribute to ion channel remodelling in heart disease.

Original languageEnglish (US)
Pages (from-to)1147-1157
Number of pages11
JournalJournal of Physiology
Volume593
Issue number5
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

Fingerprint

Ion Channels
Cardiac Myocytes
Wnt Signaling Pathway
Muscle Cells
Catenins
Heart Diseases
Wnt3A Protein
Heart Failure
Atrial Remodeling
Glycogen Synthase Kinase 3
Messenger RNA
Cardiomegaly
Recombinant Proteins
Action Potentials
Proteins
Gene Expression
Genes

ASJC Scopus subject areas

  • Physiology

Cite this

Wnt signalling suppresses voltage-dependent Na+ channel expression in postnatal rat cardiomyocytes. / Liang, Wenbin; Cho, Hee Cheol; Marbán, Eduardo.

In: Journal of Physiology, Vol. 593, No. 5, 01.03.2015, p. 1147-1157.

Research output: Contribution to journalArticle

Liang, Wenbin ; Cho, Hee Cheol ; Marbán, Eduardo. / Wnt signalling suppresses voltage-dependent Na+ channel expression in postnatal rat cardiomyocytes. In: Journal of Physiology. 2015 ; Vol. 593, No. 5. pp. 1147-1157.
@article{c588860c67294cc3a241686bf3a96285,
title = "Wnt signalling suppresses voltage-dependent Na+ channel expression in postnatal rat cardiomyocytes",
abstract = "Key points: Wnt signalling is activated in arrhythmogenic heart diseases, but its role in the regulation of cardiac ion channel expression is unknown. Exposure of neonatal rat ventricular myocytes to Wnt3a, an activator of canonical Wnt signalling, decreases Scn5a mRNA, Nav1.5 protein and Na+ current density. Wnt3a does not affect the inward rectifier K+ current or L-type Ca2+ channels. The Wnt pathway is a negative regulator of cardiac Na+ channel expression and may play a role in altered ion channel expression in heart disease. Wnt signalling plays crucial roles in heart development, but is normally suppressed postnatally. In arrhythmogenic conditions, such as cardiac hypertrophy and heart failure, Wnt signalling is reactivated. To explore the potential role of Wnt signalling in arrhythmogenic electrical remodelling, we examined voltage-dependent ion channels in cardiomyocytes. Treatment of neonatal rat ventricular myocytes with either recombinant Wnt3a protein or CHIR-99021 (CHIR, a glycogen synthase kinase-3β inhibitor) caused a dose-dependent increase in Wnt target gene expression (Axin2 and Lef1), indicating activation of the Wnt/β-catenin pathway. Cardiac Na+ current (INa) density was reduced by Wnt3a (-20 ± 4 vs. control -59 ± 7 pA pF-1, at -30 mV) or CHIR (-22 ± 5 pA pF-1), without changes in steady-state activation, inactivation or repriming kinetics. Wnt3a and CHIR also produced dose-dependent reductions in the mRNA level of Scn5a (the cardiac Na+ channel α subunit gene), as well as a 56{\%} reduction (by Wnt3a) in the Nav1.5 protein level. Consistent with INa reduction, action potentials in Wnt3a-treated neonatal rat ventricular myocytes had a lower upstroke amplitude (91 ± 3 vs. control 137 ± 2 mV) and decreased maximum upstroke velocity (70 ± 10 vs. control 163 ± 15 V s-1). In contrast, inward rectifier K+ current and L-type Ca2+ channels were not affected by Wnt3a treatment. Taken together, our data indicate that the Wnt/β-catenin pathway suppresses INa in postnatal cardiomyocytes and may contribute to ion channel remodelling in heart disease.",
author = "Wenbin Liang and Cho, {Hee Cheol} and Eduardo Marb{\'a}n",
year = "2015",
month = "3",
day = "1",
doi = "10.1113/jphysiol.2014.285551",
language = "English (US)",
volume = "593",
pages = "1147--1157",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Wnt signalling suppresses voltage-dependent Na+ channel expression in postnatal rat cardiomyocytes

AU - Liang, Wenbin

AU - Cho, Hee Cheol

AU - Marbán, Eduardo

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Key points: Wnt signalling is activated in arrhythmogenic heart diseases, but its role in the regulation of cardiac ion channel expression is unknown. Exposure of neonatal rat ventricular myocytes to Wnt3a, an activator of canonical Wnt signalling, decreases Scn5a mRNA, Nav1.5 protein and Na+ current density. Wnt3a does not affect the inward rectifier K+ current or L-type Ca2+ channels. The Wnt pathway is a negative regulator of cardiac Na+ channel expression and may play a role in altered ion channel expression in heart disease. Wnt signalling plays crucial roles in heart development, but is normally suppressed postnatally. In arrhythmogenic conditions, such as cardiac hypertrophy and heart failure, Wnt signalling is reactivated. To explore the potential role of Wnt signalling in arrhythmogenic electrical remodelling, we examined voltage-dependent ion channels in cardiomyocytes. Treatment of neonatal rat ventricular myocytes with either recombinant Wnt3a protein or CHIR-99021 (CHIR, a glycogen synthase kinase-3β inhibitor) caused a dose-dependent increase in Wnt target gene expression (Axin2 and Lef1), indicating activation of the Wnt/β-catenin pathway. Cardiac Na+ current (INa) density was reduced by Wnt3a (-20 ± 4 vs. control -59 ± 7 pA pF-1, at -30 mV) or CHIR (-22 ± 5 pA pF-1), without changes in steady-state activation, inactivation or repriming kinetics. Wnt3a and CHIR also produced dose-dependent reductions in the mRNA level of Scn5a (the cardiac Na+ channel α subunit gene), as well as a 56% reduction (by Wnt3a) in the Nav1.5 protein level. Consistent with INa reduction, action potentials in Wnt3a-treated neonatal rat ventricular myocytes had a lower upstroke amplitude (91 ± 3 vs. control 137 ± 2 mV) and decreased maximum upstroke velocity (70 ± 10 vs. control 163 ± 15 V s-1). In contrast, inward rectifier K+ current and L-type Ca2+ channels were not affected by Wnt3a treatment. Taken together, our data indicate that the Wnt/β-catenin pathway suppresses INa in postnatal cardiomyocytes and may contribute to ion channel remodelling in heart disease.

AB - Key points: Wnt signalling is activated in arrhythmogenic heart diseases, but its role in the regulation of cardiac ion channel expression is unknown. Exposure of neonatal rat ventricular myocytes to Wnt3a, an activator of canonical Wnt signalling, decreases Scn5a mRNA, Nav1.5 protein and Na+ current density. Wnt3a does not affect the inward rectifier K+ current or L-type Ca2+ channels. The Wnt pathway is a negative regulator of cardiac Na+ channel expression and may play a role in altered ion channel expression in heart disease. Wnt signalling plays crucial roles in heart development, but is normally suppressed postnatally. In arrhythmogenic conditions, such as cardiac hypertrophy and heart failure, Wnt signalling is reactivated. To explore the potential role of Wnt signalling in arrhythmogenic electrical remodelling, we examined voltage-dependent ion channels in cardiomyocytes. Treatment of neonatal rat ventricular myocytes with either recombinant Wnt3a protein or CHIR-99021 (CHIR, a glycogen synthase kinase-3β inhibitor) caused a dose-dependent increase in Wnt target gene expression (Axin2 and Lef1), indicating activation of the Wnt/β-catenin pathway. Cardiac Na+ current (INa) density was reduced by Wnt3a (-20 ± 4 vs. control -59 ± 7 pA pF-1, at -30 mV) or CHIR (-22 ± 5 pA pF-1), without changes in steady-state activation, inactivation or repriming kinetics. Wnt3a and CHIR also produced dose-dependent reductions in the mRNA level of Scn5a (the cardiac Na+ channel α subunit gene), as well as a 56% reduction (by Wnt3a) in the Nav1.5 protein level. Consistent with INa reduction, action potentials in Wnt3a-treated neonatal rat ventricular myocytes had a lower upstroke amplitude (91 ± 3 vs. control 137 ± 2 mV) and decreased maximum upstroke velocity (70 ± 10 vs. control 163 ± 15 V s-1). In contrast, inward rectifier K+ current and L-type Ca2+ channels were not affected by Wnt3a treatment. Taken together, our data indicate that the Wnt/β-catenin pathway suppresses INa in postnatal cardiomyocytes and may contribute to ion channel remodelling in heart disease.

UR - http://www.scopus.com/inward/record.url?scp=84923396039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923396039&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2014.285551

DO - 10.1113/jphysiol.2014.285551

M3 - Article

C2 - 25545365

AN - SCOPUS:84923396039

VL - 593

SP - 1147

EP - 1157

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 5

ER -